| Authors: |
Patócs A; HAS-SE 'Lendulet' Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary. patocs.attila@med.semmelweis-univ.hu.; Bionics Innovation Center, Budapest, Hungary. patocs.attila@med.semmelweis-univ.hu.; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary. patocs.attila@med.semmelweis-univ.hu., Lendvai NK; HAS-SE 'Lendulet' Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary., Butz H; HAS-SE 'Lendulet' Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.; HAS-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary., Liko I; HAS-SE 'Lendulet' Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary., Sapi Z; Department of 1st Pathology and Experimental Oncology, Semmelweis University, Budapest, Hungary., Szucs N; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary., Toth G; Ferenc Markhot County Hospital, Eger, Hungary., Grolmusz VK; HAS-SE 'Lendulet' Hereditary Endocrine Tumors Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary., Igaz P; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary., Toth M; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary., Rácz K; Bionics Innovation Center, Budapest, Hungary.; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary.; HAS-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary. |
